BioArctic AB (publ)
OTC: BRCTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Gunilla Christina Osswald
- Employees
- 131
- Headquarters
- Stockholm, Sweden
- IPO year
- 2022
- Market cap
- $3.1B
- Website
- https://www.bioarctic.se
Loading BRCTF…
Loading profile data…Frequently asked questions about BRCTF
What does BioArctic AB (publ) (BRCTF) do?
BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of innovative biological drugs, such as antibodies that address high unmet medical needs. The company's therapeutic areas encompass neurodegenerative disorders, such as Alzheimer's disease, Parkin...
Where does BRCTF trade?
BioArctic AB (publ) (BRCTF) trades on the Other OTC.
What sector is BRCTF in?
BioArctic AB (publ) (BRCTF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of BioArctic AB (publ)?
Gunilla Christina Osswald is the chief executive officer of BioArctic AB (publ) (BRCTF).
Where is BioArctic AB (publ) headquartered?
BioArctic AB (publ) is headquartered in Sweden.
Does BRCTF pay a dividend?
Yes — BioArctic AB (publ) (BRCTF) paid a trailing twelve-month dividend of USD 0.21 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BRCTF go public?
BioArctic AB (publ) (BRCTF) completed its initial public offering in 2022.